These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 3097864)
1. Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis. Gilljam H; Malmborg AS; Strandvik B Thorax; 1986 Aug; 41(8):641-6. PubMed ID: 3097864 [TBL] [Abstract][Full Text] [Related]
2. Selective media for the quantitation of bacteria in cystic fibrosis sputum. Wong K; Roberts MC; Owens L; Fife M; Smith AL J Med Microbiol; 1984 Apr; 17(2):113-9. PubMed ID: 6423825 [TBL] [Abstract][Full Text] [Related]
3. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients. van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790 [TBL] [Abstract][Full Text] [Related]
5. Serotypes and antibiotic susceptibilities of Pseudomonas aeruginosa isolates from single sputa of cystic fibrosis patients. Seale TW; Thirkill H; Tarpay M; Flux M; Rennert OM J Clin Microbiol; 1979 Jan; 9(1):72-8. PubMed ID: 107186 [TBL] [Abstract][Full Text] [Related]
6. Throat Swabs and Sputum Culture as Predictors of P. aeruginosa or S. aureus Lung Colonization in Adult Cystic Fibrosis Patients. Seidler D; Griffin M; Nymon A; Koeppen K; Ashare A PLoS One; 2016; 11(10):e0164232. PubMed ID: 27711152 [TBL] [Abstract][Full Text] [Related]
7. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis. Paixão VA; Barros TF; Mota CM; Moreira TF; Santana MA; Reis JN Braz J Infect Dis; 2010; 14(4):406-9. PubMed ID: 20963328 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of microorganisms isolated from sputum culture of patients with cystic fibrosis: Methicillin-resistant Staphylococcus aureus as a serious concern. Mazloomi Nobandegani N; Mahmoudi S; Pourakbari B; Hosseinpour Sadeghi R; Najafi Sani M; Farahmand F; Motamed F; Nabavizadeh Rafsanjani R; Mamishi S Microb Pathog; 2016 Nov; 100():201-204. PubMed ID: 27666507 [TBL] [Abstract][Full Text] [Related]
11. Paranasal sinus pathogens in children with cystic fibrosis: do they relate to lower respiratory tract pathogens and is eradication successful? Wilson P; Lambert C; Carr SB; Pao C J Cyst Fibros; 2014 Jul; 13(4):449-54. PubMed ID: 24713592 [TBL] [Abstract][Full Text] [Related]
12. [Antimicrobial susceptibility of bacterial isolates from patients with cystic fibrosis]. García AD; Ibarra A; Rodríguez FC; Casal M Rev Esp Quimioter; 2004 Dec; 17(4):332-5. PubMed ID: 15696223 [TBL] [Abstract][Full Text] [Related]
13. How to use: bacterial cultures in diagnosing lower respiratory tract infections in cystic fibrosis. Ahmed B; Bush A; Davies JC Arch Dis Child Educ Pract Ed; 2014 Oct; 99(5):181-7. PubMed ID: 24334311 [TBL] [Abstract][Full Text] [Related]
14. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. Hogardt M; Trebesius K; Geiger AM; Hornef M; Rosenecker J; Heesemann J J Clin Microbiol; 2000 Feb; 38(2):818-25. PubMed ID: 10655391 [TBL] [Abstract][Full Text] [Related]
15. [Microbiological study of the respiratory tract in children with cystic fibrosis]. Muñoz C; Juncosa T; Gené A; Fortea J; Séculi JL; Latorre C Enferm Infecc Microbiol Clin; 1996 Mar; 14(3):142-4. PubMed ID: 8695681 [TBL] [Abstract][Full Text] [Related]
16. Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. Hammerschlag MR; Harding L; Macone A; Smith AL; Goldmann DA J Clin Microbiol; 1980 Jun; 11(6):552-7. PubMed ID: 6776135 [TBL] [Abstract][Full Text] [Related]
17. Affinity for glycoproteins of bacteria found in the respiratory tract in cystic fibrosis. Saggers BA; Lawson D J Clin Pathol; 1970 Apr; 23(3):262-5. PubMed ID: 4986935 [TBL] [Abstract][Full Text] [Related]
18. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response. Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462 [TBL] [Abstract][Full Text] [Related]
19. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Bauernfeind A; Bertele RM; Harms K; Hörl G; Jungwirth R; Petermüller C; Przyklenk B; Weisslein-Pfister C Infection; 1987; 15(4):270-7. PubMed ID: 3117700 [TBL] [Abstract][Full Text] [Related]
20. Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients? Brzezinski LX; Riedi CA; Kussek P; Souza HH; Rosário N J Bras Pneumol; 2011; 37(3):341-7. PubMed ID: 21755189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]